As such, they are orienting the RESET-Myositis trial to focus on two cohorts of patients: those with dermatomyositis or antisynthetase syndrome, and those with immune-mediated necrotizing myopathy.

Provided by PR Newswire May 22, 2025, 1:15:00 PM ...

– Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – – RMAT designation granted for rese-cel in myositis, which is a disabling, multi-system ...

Idiopathic myopathies include polymyositis, dermatomyositis, non-specific myositis, and necrotizing myopathy. 1 These are very rare conditions and may be missed if one is unfamiliar with the ...

RAY-121 is under clinical development by Chugai Pharmaceutical and currently in Phase I for Immune Mediated Necrotizing Myopathy (IMNM). According to GlobalData, Phase I drugs for Immune Mediated ...

On December 13th, Gregory Charles Harrass entered his eternal rest following an eight year long battle against necrotizing myopathy and cirrhosis of the liver. He is survived by the love of his ...

Necrotizing fasciitis is a rare, life-threatening illness caused by bacteria that aggressively attack the soft tissue of the body. When you purchase through links on our site, we may earn an ...

Five of the main subtypes include dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, polymyositis, and overlap myositis, all of which can lead to significant ...

REDWOOD CITY, Calif. & BOSTON, October 16, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...

Neuropathol Appl Neurobiol. 2012;38:632-646. Liang C, Needham M. Necrotizing autoimmune myopathy. Curr Opin Rheumatol. 2011;23:612-619.

Jon Peterson, Fargo, is an extraordinary husband, father of two girls, and paramedic who was diagnosed with immune-medicated necrotizing myopathy, a rare and debilitating disease that has ...